Gaudinski, Martin R. Coates, Emily E. V. Houser, Katherine Chen, Grace L. Yamshchikov, Galina Saunders, Jamie G. A. Holman, LaSonji Gordon, Ingelise Plummer, Sarah Hendel, Cynthia S. Conan-Cibotti, Michelle Lorenzo, Margarita Gomez Sitar, Sandra Carlton, Kevin Laurencot, Carolyn T. Bailer, Robert Narpala, Sandeep B. McDermott, Adrian M. Namboodiri, Aryan P. Pandey, Janardan M. Schwartz, Richard Hu, Zonghui A. Koup, Richard Capparelli, Edmund S. Graham, Barney Mascola, John R. E. Ledgerwood, Julie Demographic characteristics of study participants. <p>Demographic characteristics of study participants.</p> Phase 1 open-label;anti-VRC 01 antibody responses;SAE;serum concentration 12 weeks;VRC 01LS;Phase IIb adult HIV;bnMAb VRC 01LS;mg;NIH;VRC 01LS administration;adults Background VRC 01;Vaccine Research Center;PK;wild-type VRC 01;CD 4-binding site;MD;prevention efficacy trial;antibody VRC 01LS;SC;SD;12- week intervals;study volunteers;AE;NCT 2018-01-24
    https://plos.figshare.com/articles/dataset/Demographic_characteristics_of_study_participants_/5818641
10.1371/journal.pmed.1002493.t001